An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients

Disease Markers

Volumn 24, Issue 3, 2008, Pages 157-165

  Traynor, Pamela ^a   McGlynn, Liane M ^a   Mukhergee, Rono ^a   Grimsley, Samuel J S ^a   Bartlett, John M S ^b   Edwards, Joanne ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

MAP kinase and proliferation; PSA

Indexed keywords

H RAS PROTEIN; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN N RAS; PROTEIN P21; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CELL CYCLE PARAMETERS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLIFERATION INDEX; PROSTATE CANCER; PROTEIN EXPRESSION; ENZYMOLOGY; METABOLISM; NEOPLASM; PROSTATE TUMOR; RECURRENT DISEASE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; NEOPLASMS, HORMONE-DEPENDENT; ONCOGENE PROTEIN P21(RAS); PROSTATIC NEOPLASMS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 44449090616     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/918087     Document Type: Article

References (32)

1. Www.Prostate_Research.Org.Uk, 2005.
2. V.J. Assikis, K.A. Do, S. Wen, X. Wang, J.H. Cho-Vega, S. Brisbay, R. Lopez, C.J. Logothetis, P. Troncoso, C.N. Papandreou and T.J. McDonnell, Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer With Limited Metastatic Potential, Clin Cancer Res 10 (2004), 6770-6778.
3. A. Bansal, R.D. Ramirez and J.D. Minna, Mutation Analysis of the Coding Sequences of MEK-1 and MEK-2 Genes in Human Lung Cancer Cell Lines, Oncogene 14 (1997), 1231-1234.
4. B.E. Barton, J.G. Karras, T.F. Murphy, A. Barton and H.F.S. Huang, Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Prostate Cancer: Direct STAT3 Inhibition Induces Apoptosis in Prostate Cancer Lines, Molecular Cancer Therapeutics 3 (2004), 11-20.
5. R.R. Berges, J. Vukanovic, J.I. Epstein, M. CarMichel, L. Cisek, D.E. Johnson, R.W. Veltri, P.C. Walsh and J.T. Isaacs, Implication of Cell Kinetic Changes During the Progression of Human Prostatic Cancer, Clin Cancer Res 1 (1995), 473-480.
6. A.M. Carey, R. Pramanik, L.J. Nicholson, T.K. Dew, F.L. Martin, G.H. Muir and J.D. Morris, Ras-MEK-ERK Signaling Cascade Regulates Androgen Receptor Element-Inducible Gene Transcription and DNA Synthesis in Prostate Cancer Cells, Int J Cancer 121 (2007), 520-527.
7. T. Chen, K. Dhingra, A. Sahin, N. Sneige, G. Hortobagyi and C.M. Aldaz, Technical Approach for the Study of the Genetic Evolution of Breast Cancer From Paraffin Embedded Tissue Sections, Breast Cancer Research and Treatment 39 (1996), 177-185.
8. J. Edwards and J.M. Bartlett, The Androgen Receptor and Signal-Transduction Pathways in Hormone-Refractory Prostate Cancer. Part 1: Modifications to the Androgen Receptor, BJU Int 95 (2005), 1320-1326.
9. J. Edwards and J.M. Bartlett, The Androgen Receptor and Signal-Transduction Pathways in Hormone-Refractory Prostate Cancer. Part 2: Androgen-Receptor Cofactors and Bypass Pathways, BJU Int 95 (2005), 1327-1335.
10. J. Edwards, N.S. Krishna, C.J. Witton and J.M.S. Bartlett, Gene Amplifications Associated With the Development of Hormone Resistant Prostate Cancer, Clinical Cancer Research 9 (2003), 5271-5281.
11. J. Edwards, P. Traynor, A.F. Munro, C.F. Pirret, B. Dunne and J.M. Bartlett, The Role of HER1-HER4 and EGFRvIII in Hormone-Refractory Prostate Cancer, Clin Cancer Res 12 (2006), 123-130.
12. S. Erlich, P. Tal-Or, R. Liebling, R. Blum, D. Karunagaran, Y. Kloog and R. Pinkas-Kramarski, Ras Inhibition Results in Growth Arrest and Death of Androgen-Dependent and Androgen-Independent Prostate Cancer Cells, Biochem Pharmacol 72 (2006), 427-436.
13. L.A. Feig and R.J. Buchsbaum, Cell Signaling: Life or Death Decisions of Ras Proteins, Current Biology 12 (2002), R259-R261.
14. D. Gioeli, J.W. Mandell, G.R. Petroni, H.F. Frierson and M.J. Weber, Activation of Mitogen-Activated Protein Kinase Associated With Prostate Cancer Progression, Cancer Res 59 (1999), 279-284.
15. S.M. Hamdy, A.G. Aprikian, L.R. Begin, W.R. Fair and M. Bazinet, Ras P21 Overexpression Is A Late Event in Prostate-Cancer, International Journal of Oncology 4 (1994), 627-631.
16. J.F. Hancock, Ras Proteins: Different Signals From Different Locations, Nature Reviews Molecular Cell Biology 4 (2003), 373-384.
17. M. Hilmy, R. Campbell, J.M. Bartlett, A.M. McNicol, M.A. Underwood and D.C. McMillan, The Relationship Between the Systemic Inflammatory Response, Tumour Proliferative Activity, T-Lymphocytic Infiltration and COX-2 Expression and Survival in Patients With Transitional Cell Carcinoma of the Urinary Bladder, Br J Cancer 95 (2006), 1234-1238.
18. L.M. Hu, C. Zaloudek, G.B. Mills, J. Gray and R.B. Jaffe, In Vivo and in Vitro Ovarian Carcinoma Growth Inhibition by a Phosphatidylinositol 3-Kinase Inhibitor (LY294002), Clinical Cancer Research 6 (2000), 880-886.
19. T. Kirkegaard, J. Edwards, S. Tovey, L.M. McGlynn, S.N. Krishna, R. Mukherjee, L. Tam, A.F. Munro, B. Dunne and J.M. Bartlett, Observer Variation in Immunohistochemical Analysis of Protein Expression, Time for a Change? Histopathology 48 (2006), 787-794.
20. W. Kolch, Meaningful Relationships: the Regulation of the Ras/Raf/MEK/ERK Pathway by Protein Interactions, Biochemical Journal 351 (2000), 289-305;
21. Biochemical Journal 351 (2006), 289-305.
22. K.S. McCarty, Jr., E. Szabo, J.L. Flowers, E.B. Cox, G.S. Leight, L. Miller, J. Konrath, J.T. Soper, D.A. Budwit and W.T. Creasman, Use of a Monoclonal Anti-Estrogen Receptor Antibody in the Immunohistochemical Evaluation of Human Tumors, Cancer Res 46 (1986), 4244s-4248s.
23. J.A. McCubrey, L.S. Steelman, W.H. Chappell, S.L. Abrams, E.W.Wong, F. Chang, B. Lehmann, D.M. Terrian, M. Milella, A. Tafuri, F. Stivala, M. Libra, J. Basecke, C. Evangelisti, A.M. Martelli and R.A. Franklin, Roles of the Raf/MEK/ERK Pathway in Cell Growth, Malignant Transformation and Drug Resistance, Biochim Biophys Acta (2006).
24. R. Mukherjee, S.K. Nalagatla, M.A. Underwood, J.M.S. Bartlett and J. Edwards, The Raf/MAP Kinase Pathway Influences Survival in Androgen-Insensitive Prostate Cancer, Journal of Urology 173 (2005), 157-158.
25. R. Mukherjee, J.M. Bartlett, N.S. Krishna, M.A. Underwood and J. Edwards, Raf-1 Expression May Influence Progression to Androgen Insensitive Prostate Cancer, Prostate 64 (2005), 101-107.
26. N.K. Mukhopadhyay, B. Cinar, L. Mukhopadhyay, M. Lutchman, A.S. Ferdinand, J. Kim, L.W. Chung, R.M. Adam, S.K. Ray, A.B. Leiter, J.P. Richie, B.C. Liu and M.R. Freeman, The Zinc Finger Protein RREB-1 Is a Co-Regulator of the Androgen Receptor: Implications for the Role of the Ras Pathway in Enhancing Androgenic Signaling in Prostate Cancer, Mol Endocrinol (2007).
27. R.G. Pergolizzi, W. Kreis, C. Rottach, M. Susin and J.D. Broome, Mutational Status of Codon-12 and Codon-13 of the N-Ras and K- Ras Genes in Tissue and Cell-Lines Derived From Primary and Metastatic Prostate Carcinomas, Cancer Investigation 11 (1993), 25-32.
28. G.W. Reuther and C.J. Der, The Ras Branch of Small Gtpases: Ras Family Members Don't Fall Far From the Tree, Current Opinion in Cell Biology 2000 (2006), 157-165.
29. T. Shiraishi, T. Muneyuki, K. Fukutome, H. Ito, T. Kotake, M. Watanabe and R. Yatani, Mutations of Ras Genes Are Relatively Frequent in Japanese Prostate Cancers: Pointing to Genetic Differences Between Populations, Anticancer Research 18 (1998), 2789-2792.
30. L. Tam, L.M. McGlynn, P. Traynor, R. Mukherjee, J.M. Bartlett and J. Edwards, Expression Levels of the JAK/STAT Pathway in the Transition From Hormone-Sensitive to Hormone-Refractory Prostate Cancer, Br J Cancer (2007).
31. M.J. Weber and D. Gioeli, Ras Signaling in Prostate Cancer Progression, Journal of Cellular Biochemistry 91 (2004), 13-25.
32. X. Zhu and J.P. Liu, Steroid-Independent Activation of Androgen Receptor in Androgen-Independent Prostate Cancer: a Possible Role for the MAP Kinase Signal Transduction Pathway? Molecular & Cellular Endocrinology 134 (1997), 9-14.